Market Place
Sourcing Support
All News #Library
Biotech
Avacta Therapeutics Presents Data at 2025 AACR Annual Meeting
28 Apr 2025 //
GLOBENEWSWIRE
Avacta Therapeutics Presents Data on FAP-Dox at 2025 AACR Meeting
28 Apr 2025 //
GLOBENEWSWIRE
Avacta`s Business Update for Q1 2025 on Strategic Progress
31 Mar 2025 //
GLOBENEWSWIRE
Avacta reports positive data for AVA6000 in Phase 1 trials
07 Mar 2025 //
GLOBENEWSWIRE
Avacta Reports Tumor Shrinkage Data From AVA6000 Phase 1 Trial
16 Jan 2025 //
GLOBENEWSWIRE
Avacta Reports Pipeline Advances At EORTC-NCI-AACR Symposium
24 Oct 2024 //
GLOBENEWSWIRE
Avacta Group Strengthens Team With Michelle Morrow As CSO
15 Oct 2024 //
GLOBENEWSWIRE
Avacta To Present AVA6000 Data At ESMO Congress
08 Sep 2024 //
GLOBENEWSWIRE
Avacta Group - AVA6000 Abstract Release by AACR and Full Presentation Update
05 Apr 2024 //
GLOBENEWSWIRE
Updated Results from Single-Agent Phase 1 of Peptide Drug Conjugate, AVA6000
05 Mar 2024 //
GLOBENEWSWIRE
Avacta Announces Successful Completion of Fifth Dose Escalation in AVA6000
21 Jun 2023 //
BUSINESSWIRE
Avacta enrolls fifth patient in cohort of AVA6000 phase Ia dose escalation study
08 Apr 2023 //
PHARMABIZ
Avacta Opens First Two US Clinical Investigator Sites for AVA6000 Phase 1 Study
06 Apr 2023 //
BUSINESSWIRE
Avacta Announces First Patient Dosed in Cohort of AVA6000 PhIa Escalation Study
05 Apr 2023 //
BUSINESSWIRE
Avacta Announces Completion of Fourth Dose Escalation in AVA6000 Phase 1 Study
17 Jan 2023 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.